Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction
Michelle Chan, Rajalakshmi Santhanakrishnan, Jenny Chong, et al.
European Journal of Heart Failure (2015) Vol. 18, Iss. 1, pp. 81-88
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Co-regulatory networks of human serum proteins link genetics to disease
Valur Emilsson, Marjan Ilkov, John R. Lamb, et al.
Science (2018) Vol. 361, Iss. 6404, pp. 769-773
Open Access | Times Cited: 549
Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
Milton Packer
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 20, pp. 2360-2372
Closed Access | Times Cited: 477
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert, Tibor Kempf, Lars Wallentin
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 140-151
Open Access | Times Cited: 453
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Jasper Tromp, B. Daan Westenbrink, Wouter Ouwerkerk, et al.
Journal of the American College of Cardiology (2018) Vol. 72, Iss. 10, pp. 1081-1090
Open Access | Times Cited: 252
Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction
Camilla Hage, Erik Michaëlsson, Cecilia Linde, et al.
Circulation Cardiovascular Genetics (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 142
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
Danna M. Breen, Hanna Kim, Donald Bennett, et al.
Cell Metabolism (2020) Vol. 32, Iss. 6, pp. 938-950.e6
Open Access | Times Cited: 122
Variability of biomarkers in patients with chronic heart failure and healthy controls
Wouter C. Meijers, A. Rogier van der Velde, Anneke C. Muller Kobold, et al.
European Journal of Heart Failure (2016) Vol. 19, Iss. 3, pp. 357-365
Open Access | Times Cited: 121
Novel biomarkers of cardiovascular disease: Applications in clinical practice
Magnus Nakrem Lyngbakken, Peder L. Myhre, Helge Røsjø, et al.
Critical Reviews in Clinical Laboratory Sciences (2018) Vol. 56, Iss. 1, pp. 33-60
Open Access | Times Cited: 121
Biomarkers for heart failure: small molecules with high clinical relevance
Christina Magnussen, Stefan Blankenberg
Journal of Internal Medicine (2018) Vol. 283, Iss. 6, pp. 530-543
Open Access | Times Cited: 109
Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers
Alexander Е. Berezin, Alexander A. Berezin
Disease Markers (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 109
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du, Arnold Piek, Elisabeth M. Schouten, et al.
Theranostics (2018) Vol. 8, Iss. 15, pp. 4155-4169
Open Access | Times Cited: 84
Sex‐related differences in contemporary biomarkers for heart failure: a review
Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 5, pp. 775-788
Open Access | Times Cited: 83
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
W. Andrew Owens, Anna Walaszczyk, Ioakim Spyridopoulos, et al.
Mechanisms of Ageing and Development (2021) Vol. 198, pp. 111540-111540
Open Access | Times Cited: 81
Machine Learning-Derived Echocardiographic Phenotypes Predict Heart Failure Incidence in Asymptomatic Individuals
Masatake Kobayashi, Olivier Huttin, Martin Magnusson, et al.
JACC. Cardiovascular imaging (2021) Vol. 15, Iss. 2, pp. 193-208
Open Access | Times Cited: 63
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 51
Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
Farah Omran, Ioannis Kyrou, Faizel Osman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5680-5680
Open Access | Times Cited: 40
Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure
Abhinav Sharma, Susanna R. Stevens, Joseph Lucas, et al.
JACC Heart Failure (2017) Vol. 5, Iss. 10, pp. 724-734
Open Access | Times Cited: 86
Various aspects of inflammation in heart failure
Mieczysław Dutka, Rafał Bobiński, Izabela Ulman-Włodarz, et al.
Heart Failure Reviews (2019) Vol. 25, Iss. 3, pp. 537-548
Open Access | Times Cited: 75
Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction
M Boulogne, Malha Sadoune, J-M. Launay, et al.
International Journal of Cardiology (2016) Vol. 226, pp. 53-59
Closed Access | Times Cited: 66
Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player
Marian Wesseling, Julius H.C. de Poel, Saskia C.A. de Jager
ESC Heart Failure (2020) Vol. 7, Iss. 4, pp. 1488-1501
Open Access | Times Cited: 66
Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
Mihaela Mocan, Larisa Diana Mocan Hognogi, Florin Petru Anton, et al.
Disease Markers (2019) Vol. 2019, pp. 1-14
Open Access | Times Cited: 58
Biomarkers in Heart Failure with Preserved Ejection Fraction
Antoni Bayés‐Genís, Germán Cediel, Mar Domingo, et al.
Cardiac failure review (2022) Vol. 8
Open Access | Times Cited: 34
Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management
Khalid Sawalha, Nicholas B. Norgard, Betty M. Drees, et al.
Current Heart Failure Reports (2023) Vol. 20, Iss. 4, pp. 287-299
Closed Access | Times Cited: 16
Biomarkers for characterization of heart failure – Distinction of heart failure with preserved and reduced ejection fraction
Christoph Sinning, Tibor Kempf, Michael Schwarzl, et al.
International Journal of Cardiology (2016) Vol. 227, pp. 272-277
Closed Access | Times Cited: 60
Page 1 - Next Page

Scroll to top